Scheltens, P. et al. Alzheimer’s disease. Lancet 397, 1577–1590 (2021).
Nyberg, L. et al. Biological and environmental predictors of heterogeneity in neurocognitive ageing: Evidence from Betula and other longitudinal studies. Ageing Res. Rev. https://doi.org/10.1016/j.arr.2020.101184 (2020).
Serrano-Pozo, A., Das, S. & Hyman, B. T. APOE and Alzheimer’s disease: Advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 20, 68–80 (2021).
Montagne, A. et al. APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline. Nature 581, 71–76 (2020).
Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat. Genet. 51, 414–430 (2019).
Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat. Genet. 51, 404–413 (2019).
Bellou, E., Stevenson-Hoare, J. & Escott-Price, V. Polygenic risk and pleiotropy in neurodegenerative diseases. Neurobiol. Dis. 142, 104953 (2020).
Kauppi, K., Rönnlund, M., Nordin Adolfsson, A., Pudas, S. & Adolfsson, R. Effects of polygenic risk for Alzheimer’s disease on rate of cognitive decline in normal aging. Transl. Psychiatry https://doi.org/10.1038/s41398-020-00934-y (2020).
Li, J.-Q., Tan, L., Wang, H.-F., Tan, M.-S., Tan, L., Xu, W. et al. Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: A systematic review and meta-analysis of cohort studies. J. Neurol. Neurosurg. Psychiatry 1–9 (2016).
Murray, A. N., Chandler, H. L. & Lancaster, T. M. Multimodal hippocampal and amygdala subfield volumetry in polygenic risk for Alzheimer’s disease. Neurobiol. Aging 98, 33–41 (2021).
Foley, S. F. et al. Multimodal brain imaging reveals structural differences in Alzheimer’s disease polygenic risk carriers: A study in healthy young adults. Biol. Psychiatry 81, 154–161 (2017).
Foo, H. et al. Associations between Alzheimer’s disease polygenic risk scores and hippocampal subfield volumes in 17,161 UK Biobank participants. Neurobiol. Aging 98, 108–115 (2021).
Gorbach, T. et al. Longitudinal association between hippocampus atrophy and episodic-memory decline in non-demented APOE ε4 carriers. Alzheimer’s Dement. Diagn. Assess. Dis. Monit. 12, 1–9 (2020).
Machulda, M. M. et al. Comparison of memory fMRI response among normal, MCI, and Alzheimer’s patients. Neurology 61, 500–506 (2003).
Johnson, S. C. et al. Activation of brain regions vulnerable to Alzheimer’s disease: The effect of mild cognitive impairment. Neurobiol. Aging 27, 1604–1612 (2006).
Petrella, J. R. et al. Mild cognitive impairment: Evaluation with 4-T functional MR imaging. Radiology 240, 177–186 (2006).
Dickerson, B. C. et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann. Neurol. 56, 27–35 (2004).
Dickerson, B. C. et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 65, 404–411 (2005).
Celone, K. A. et al. Alterations in memory networks in mild cognitive impairment and Alzheimer’s disease: An independent component analysis. J. Neurosci. 26, 10222–10231 (2006).
Hämäläinen, A. et al. Increased fMRI responses during encoding in mild cognitive impairment. Neurobiol. Aging 28, 1889–1903 (2007).
Kircher, T. T. et al. Hippocampal activation in patients with mild cognitive impairment is necessary for successful memory encoding. J. Neurol. Neurosurg. Psychiatry 78, 812–818 (2007).
Yassa, M. A. et al. High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic mild cognitive impairment. Neuroimage 51, 1242–1252 (2010).
Filippini, N. et al. Distinct patterns of brain activity in young carriers of the APOE-ε4 allele. Proc. Natl. Acad. Sci. U. S. A. 106, 7209–7214 (2009).
Trachtenberg, A. J., Filippini, N. & Mackay, C. E. The effects of APOE-ε4 on the BOLD response. Neurobiol. Aging 33, 323–334 (2012).
Bookheimer, S. Y. et al. Patterns of brain activation in people at risk for Alzheimer’s disease. N. Engl. J. Med. 343, 450–456 (2000).
Trivedi, M. A. et al. fMRI activation during episodic encoding and metacognitive appraisal across the lifespan: Risk factors for Alzheimer’s disease. Neuropsychologia 46, 1667–1678 (2008).
Dennis, N. A. et al. Temporal lobe functional activity and connectivity in young adult APOE ε4 carriers. Alzheimer’s Dement. 6, 303–311 (2010).
Adamson, M. M., Hutchinson, J. B., Shelton, A. L., Wagner, A. D. & Taylor, J. L. Reduced hippocampal activity during encoding in cognitively normal adults carrying the APOE e{open}4 allele. Neuropsychologia 49, 2448–2455 (2011).
Chandler, H. L., Hodgetts, C. J., Caseras, X., Murphy, K. & Lancaster, T. M. Polygenic risk for Alzheimer’s disease shapes hippocampal scene-selectivity. Neuropsychopharmacology 45, 1171–1178 (2020).
Xiao, E. et al. Late-onset Alzheimer’s disease polygenic risk profile score predicts hippocampal function. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 2, 673–679 (2017).
Nyberg, L., Andersson, M., Lundquist, A., Salami, A. & Wåhlin, A. Frontal contribution to hippocampal hyperactivity during memory encoding in aging. Front. Mol. Neurosci. 12, 1–11 (2019).
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., Text Revision), Text Revision (2000).
Rönnlund, M., Sundström, A., Adolfsson, R. & Nilsson, L. G. Subjective memory impairment in older adults predicts future dementia independent of baseline memory performance: Evidence from the Betula prospective cohort study. Alzheimer’s Dement. 11, 1385–1392 (2015).
Nilsson, L.-G. et al. Betula: A prospective cohort study on memory, health and aging. Aging Neuropsychol. Cogn. 11, 134–148 (2004).
Persson, J., Kalpouzos, G., Nilsson, L., Ryberg, M. & Nyberg, L. Preserved hippocampus activation in normal aging as revealed by fMRI. Hippocampus 21, 753–766 (2011).
Pudas, S. et al. Brain characteristics of individuals resisting age-related cognitive decline over two decades. J. Neurosci. 15, 8668–8677 (2013).
Ashburner, J. A fast diffeomorphic image registration algorithm. Neuroimage 38, 95–113 (2007).
Poppenk, J., Evensmoen, H. R., Moscovitch, M. & Nadel, L. Long-axis specialization of the human hippocampus. Trends Cogn. Sci. 17, 230–240 (2013).
The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68–74 (2016).
Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955–959 (2013).
O’Donoghue, M. C., Murphy, S. E., Zamboni, G., Nobre, A. C. & Mackay, C. E. APOE genotype and cognition in healthy individuals at risk of alzheimer’s disease: A review. Cortex 104, 103–123 (2018).
Talwar, P., Kushwaha, S., Chaturvedi, M., Mahajan, V. Systematic review of different neuroimaging correlates in mild cognitive impairment and Alzheimer’s disease. Clin. Neuroradiol. 953–967 (2021).
Li, H. J. et al. Toward systems neuroscience in mild cognitive impairment and Alzheimer’s disease: A meta-analysis of 75 fMRI studies. Hum. Brain Mapp. 36, 1217–1232 (2015).
Halliday, M. R. et al. Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease. J. Cereb. Blood Flow Metab. 36, 216–227 (2016).
Wåhlin, A. & Nyberg, L. At the heart of cognitive functioning in aging. Trends Cogn. Sci. 23, 717–720 (2019).
Iadecola, C. The neurovascular unit coming of age: A journey through neurovascular coupling in health and disease. Neuron 96(17–42), 48 (2017).
Martens, Y. A. et al. ApoE cascade hypothesis in the pathogenesis of Alzheimer’s disease and related dementias. Neuron 110, 1304–1317 (2022).
Nyberg, L. Functional brain imaging of episodic memory decline in ageing. J. Intern. Med. 281, 65–74 (2017).
Tromp, D., Dufour, A., Lithfous, S., Pebayle, T. & Després, O. Episodic memory in normal aging and Alzheimer disease: Insights from imaging and behavioral studies. Ageing Res. Rev. 24, 232–262 (2015).
Salami, A., Eriksson, J. & Nyberg, L. Opposing effects of aging on large-scale brain systems for memory encoding and cognitive control. J. Neurosci. 32, 10749–10757 (2012).
Pu-Ting, X. et al. Specific regional transcription of apolipoprotein E in human brain neurons. Am. J. Pathol. 154, 601–611 (1999).
Zhang, Q., Sidorenko, J., Couvy-duchesne, B., Marioni, R. E., Wright, M. J., Goate, A. M., et al. Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture. Nat. Commun. 1–11 (2020).
Hill, W. D., Marioni, R. E., Maghzian, O., Ritchie, S. J., Hagenaars, S. P., McIntosh, A. M., et al. A combined analysis of genetically correlated traits identifies 187 loci and a role for neurogenesis and myelination in intelligence. Mol. Psychiatry 1–13 (2018).
Jack, C. R. et al. Prevalence of biologically vs clinically defined alzheimer spectrum entities using the national institute on aging-Alzheimer’s association research framework. JAMA Neurol. 55905, 1–10 (2019).